STOCK TITAN

Insider at BiomX (PHGE) files Form 3 on preferred stock, warrants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

BiomX Inc. director and 10% owner Reuven Yeganeh filed an initial Form 3 reporting indirect holdings through Pyu Pyu Capital, LLC as of January 13, 2026. The filing shows Series Y Convertible Preferred Stock initially convertible into 1,650,000 shares of common stock at $2.00 per share, with customary anti-dilution adjustments and potential further adjustment upon requisite stockholder approval. It also reports Common Stock Purchase Warrants for 3,300,000 shares of common stock at an exercise price of $2.00, exercisable from January 2, 2026 and expiring on January 2, 2031. According to the filing, Pyu Pyu Capital, LLC holds these securities, and Yeganeh is its sole member with sole voting and dispositive power.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Yeganeh Reuven

(Last) (First) (Middle)
C/O BIOMX INC.
22 EINSTEIN ST., FLOOR 4

(Street)
NESS ZIONA IL 414003

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/13/2026
3. Issuer Name and Ticker or Trading Symbol
BiomX Inc. [ PHGE ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series Y Convertible Preferred Stock 01/02/2026 12/29/2026 Common Stock 1,650,000 $2(1) I By Pyu Pyu Capital, LLC(2)
Common Stock Purchase Warrants 01/02/2026 01/02/2031 Common Stock 3,300,000 $2 I By Pyu Pyu Capital, LLC(2)
Explanation of Responses:
1. Each share of Series Y Convertible Preferred Stock is initially convertible into common stock at a conversion price of $2.00 per share, subject to customary anti-dilution adjustments for stock splits, stock dividends, recapitalizations and similar transactions. In addition, upon receipt of the requisite stockholder approval, the conversion price may be adjusted as provided in the Certificate of Designation.
2. The reported securities are held by Pyu Pyu Capital, LLC, of which the reporting person is the sole member, and over which the reporting person exercises sole voting and dispositive power.
/s/ Reuven Yeganeh 01/16/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Biomx Inc

NYSE:PHGE

PHGE Rankings

PHGE Latest News

PHGE Latest SEC Filings

PHGE Stock Data

3.98M
1.26M
18.81%
44.48%
1.89%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Israel
NESS ZIONA